Facts & Figures

Diagnosed mild cognitive impairment (MCI) is associated with a risk of developing dementia¹¹
Mild cognitive impairment is considered a transitional stage between normal aging and the earliest stage when Alzheimer’s disease can currently be diagnosed¹²
Studies indicate that as many as 10-20% of people aged 65 and older have mild cognitive impairment¹³
Clinical research with those suffering with mild cognitive impairment suggests the conversion to dementia is 10-15% per year¹²
Comparatively, just 1-2% of a normal, age-matched, non-clinical population sample will develop dementia each year¹²
Not everyone diagnosed with mild cognitive impairment will go on to develop dementia¹⁴
Alzheimer’s disease is the most common form of dementia
Alzheimer’s disease is estimated to affect 25 million people around the world with the number of diagnosed cases expected to rise dramatically in the near future¹⁵
In the next few decades, extraordinary efforts will be spent on the prevention and treatment of dementia, because this illness will affect about 63 million people by 2030, and 114 million by 2050 worldwide¹⁵
Research has focused on developing pharmaceutical treatments for Alzheimer’s disease, with an increasing emphasis on early accurate diagnosis and intervention
If preventative therapies are found that can delay the onset of Alzheimer’s disease by even 5 years, the impact of this illness could be reduced by half¹⁶

Languages